Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.0768 EUR
−125.47 M EUR
1.21 M EUR
106.89 M
About GRITSTONE BIO DL-,0001
Sector
Industry
CEO
Andrew R. Allen
Website
Headquarters
Emeryville
Founded
2015
FIGI
BBG00M54MXX4
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GRITSTONE BIO DL-,0001 stocks are traded under the ticker 2JQ.
Yes, you can track GRITSTONE BIO DL-,0001 financials in yearly and quarterly reports right on TradingView.
GRITSTONE BIO DL-,0001 is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
2JQ earnings for the last quarter are −0.15 EUR per share, whereas the estimation was −0.15 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.15 EUR per share. See more details about GRITSTONE BIO DL-,0001 earnings.
GRITSTONE BIO DL-,0001 revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
2JQ net income for the last quarter is −21.84 M EUR, while the quarter before that showed −37.43 M EUR of net income which accounts for 41.64% change. Track more GRITSTONE BIO DL-,0001 financial stats to get the full picture.
No, 2JQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 5, 2024, the company has 231.00 employees. See our rating of the largest employees — is GRITSTONE BIO DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRITSTONE BIO DL-,0001 EBITDA is −133.83 M EUR, and current EBITDA margin is −11.05 K%. See more stats in GRITSTONE BIO DL-,0001 financial statements.
Like other stocks, 2JQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRITSTONE BIO DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.